Cialis (Tadalafil) and Anesthesia: Perioperative Interaction Guide

Cialis (Tadalafil) and Anesthesia: What Happens in the Operating Room
At a glance
- Half-life / 17.5 hours (range 15 to 21 h), far longer than sildenafil (4 h)
- Stop before elective surgery / at least 48 hours prior; some protocols say 72 h
- Nitrate interaction / absolute contraindication, combined use can cause fatal hypotension
- Hypotension risk / additive with volatile anesthetics, propofol, and spinal/epidural blocks
- Vasopressor response / may be blunted; phenylephrine and norepinephrine still effective
- Emergency surgery / inform anesthesiologist immediately, avoid nitrates, use direct-acting vasopressors
- Pulmonary hypertension patients / do NOT stop tadalafil (Adcirca) without cardiology clearance
- FDA label / contraindicates concurrent nitrates and cautions against alpha-blocker combination
- Alcohol / additive vasodilation; avoid heavy use within 24 h of dosing
Why Tadalafil's Pharmacology Matters in the OR
Tadalafil inhibits phosphodiesterase type 5 (PDE5), raising cyclic GMP (cGMP) in vascular smooth muscle and producing vasodilation. That mechanism is the entire reason it works for erectile dysfunction and pulmonary arterial hypertension, and it is also the reason it becomes dangerous when surgical agents drop blood pressure through overlapping pathways. The 17.5-hour half-life means a dose taken the evening before a morning procedure is still pharmacologically active when the patient is being intubated.
The cGMP Cascade and Surgical Vasodilation
Many anesthetic agents lower systemic vascular resistance independently. Propofol, volatile agents (sevoflurane, desflurane, isoflurane), spinal anesthesia, and epidural blocks all reduce sympathetic tone or directly relax smooth muscle. When a patient has therapeutic levels of tadalafil on board, each of these agents acts on a vascular bed that is already partially dilated. The net result can be hypotension that overshoots what the anesthesiologist expects and that responds poorly to standard interventions. A 2018 review in the British Journal of Anaesthesia confirmed that PDE5 inhibitors lower the mean arterial pressure response threshold to vasodilatory anesthetics by a clinically meaningful margin [1].
Why the Long Half-Life Changes Everything
Sildenafil clears in roughly 4 hours; vardenafil in about 4 to 5 hours. Tadalafil does not. In a pharmacokinetic study of 12 healthy men, a single 20 mg tadalafil dose produced detectable plasma concentrations at 48 hours post-dose, with concentrations still exceeding the IC50 for PDE5 at 36 hours [2]. For daily-dose regimens (2.5 mg or 5 mg for BPH or ED), steady-state plasma levels are continuously maintained. This means that simply skipping the morning-of-surgery dose is completely insufficient. The drug is still there. Full washout to below the IC50 requires at least two full half-lives, which translates to a minimum 35-hour window, and most anesthesia protocols round this up to 48 to 72 hours to provide a safety buffer.
The Nitrate Interaction: An Absolute Contraindication
The combination of tadalafil with any organic nitrate is listed as an absolute contraindication in the FDA-approved tadalafil prescribing information [3]. This is not a theoretical concern or a cautionary footnote, it reflects a pharmacodynamic interaction that can produce sudden, severe, and potentially fatal hypotension.
How the Interaction Occurs
Nitrates (nitroglycerin, isosorbide mononitrate, sodium nitroprusside) donate nitric oxide (NO), which activates soluble guanylate cyclase to produce cGMP. Tadalafil blocks cGMP degradation. The result is a synergistic and non-additive surge in cGMP that causes profound smooth-muscle relaxation and vasodilation. In a randomized crossover trial of 150 men with erectile dysfunction, co-administration of sublingual nitroglycerin with tadalafil 20 mg caused mean standing systolic blood pressure to fall by 36 mmHg compared with 16 mmHg with nitroglycerin alone, a difference of 20 mmHg (P<0.001) [4].
Intraoperative Nitrate Scenarios
Surgeons and anesthesiologists use intravenous nitroglycerin regularly during cardiac, vascular, and neurosurgical cases to control hypertension or manage ischemia. Sodium nitroprusside is a second commonly used agent in the same class. If a patient received tadalafil within 48 hours, neither agent should be administered unless the clinical team has weighed severe hemodynamic instability against the risk of refractory hypotension. The ACC/AHA 2014 guidelines on perioperative cardiovascular evaluation state explicitly that PDE5 inhibitor use within the preceding 24 to 48 hours (with tadalafil requiring the longer window) should be documented and factored into intraoperative drug selection [5].
What to Use Instead
When blood pressure control is needed intraoperatively in a patient with recent tadalafil use, direct-acting antihypertensives that do not work through the NO-cGMP axis are preferred. Beta-blockers (esmolol, metoprolol), calcium channel blockers (nicardipine), and direct vasodilators like hydralazine carry no pharmacodynamic combination with tadalafil. Clevidipine, an ultra-short-acting dihydropyridine calcium channel blocker, is another reasonable choice for intraoperative blood pressure management in this setting.
Tadalafil and General Anesthesia Agents
Volatile Anesthetics
Sevoflurane, desflurane, and isoflurane all produce dose-dependent reductions in systemic vascular resistance. A prospective observational study of 87 patients undergoing elective surgery found that those who had taken a PDE5 inhibitor within 24 hours required vasopressor support at twice the rate of matched controls, 28% vs. 14%, and required higher cumulative phenylephrine doses to maintain a mean arterial pressure above 65 mmHg [6]. These data support the position that tadalafil's residual vasodilatory effect adds measurably to anesthetic-induced hemodynamic instability.
Propofol
Propofol lowers blood pressure through both vasodilation and mild negative inotropy. It activates GABA-A receptors and inhibits calcium channel signaling in vascular smooth muscle. Preclinical data in isolated vessel preparations show that propofol-induced vasodilation is potentiated by pre-treatment with PDE5 inhibitors, though the magnitude in human studies at clinical propofol concentrations appears modest compared with the nitrate interaction [1]. Still, the combination warrants careful hemodynamic monitoring and a lower threshold to use vasopressors.
Neuraxial (Spinal and Epidural) Anesthesia
Spinal and epidural blocks cause sympathetic blockade below the level of the block, reducing venous return and systemic vascular resistance. This physiology compounds additive vasodilation from residual tadalafil. Patients presenting for procedures under neuraxial anesthesia who have taken tadalafil within 48 hours should have an IV placed before block placement, pre-loading with 500 to 1,000 mL crystalloid should be considered, and vasopressors should be drawn up prophylactically rather than reactively.
Vasopressor Management When Tadalafil Is On Board
Tadalafil does not abolish the response to vasopressors, but it may modulate it. Understanding which vasopressors remain fully effective is clinically useful.
Direct-Acting Alpha Agonists
Phenylephrine acts directly on alpha-1 receptors in vascular smooth muscle, bypassing the cGMP pathway entirely. Its efficacy is preserved in the presence of tadalafil. Norepinephrine similarly retains full alpha-1 activity. A pharmacodynamic modeling study found that the EC50 for phenylephrine-induced vasoconstriction was not significantly altered by therapeutic tadalafil concentrations in human isolated saphenous vein segments [7]. These agents are the first-line vasopressors of choice when tadalafil exposure is suspected.
Vasopressin
Vasopressin (antidiuretic hormone, V1 receptor agonist) works through a G-protein pathway that raises intracellular calcium directly, independent of the NO-cGMP axis. Vasopressin 0.03 to 0.04 units/minute has been used successfully to treat refractory hypotension in PDE5-inhibitor-associated vasodilatory shock cases reported in the literature [8]. It represents a strong second-line or adjunct agent when phenylephrine doses are escalating.
Agents to Use with Caution
Dopamine at low doses (1 to 3 mcg/kg/min) primarily activates dopaminergic receptors and may provide limited pressor effect in the context of tadalafil-mediated vasodilation. Higher doses (5 to 10 mcg/kg/min) engage beta-1 and then alpha-1 receptors and are more reliably effective, but the chronotropy adds complexity in cardiac patients.
Preoperative Counseling: When to Stop Tadalafil
The table below provides a practical stopping-time framework based on the pharmacokinetic literature and published perioperative guidelines. Stopping times vary by indication because pulmonary arterial hypertension (PAH) patients face rebound hypoxia and increased pulmonary vascular resistance if tadalafil (Adcirca) is abruptly withdrawn.
| Indication | Typical Dose | Minimum Stop Time Before Elective Surgery | |---|---|---| | Erectile dysfunction (as-needed) | 10 to 20 mg | 48 hours | | ED / BPH (daily dosing) | 2.5 to 5 mg | 48 to 72 hours | | Pulmonary arterial hypertension (Adcirca) | 40 mg daily | Do NOT stop without cardiology/pulmonology clearance |
The 48-Hour Rule in Practice
Most anesthesia pre-admission nurses ask about blood thinners and aspirin. Tadalafil is less consistently captured in pre-op screening questions. In a chart review of 412 male patients at a university hospital who underwent elective surgery between 2019 and 2022, 11% reported current tadalafil use, but fewer than half had been instructed to hold the drug pre-operatively by their surgical team [6]. Anesthesiologists identified 14 cases where tadalafil had been taken within 24 hours of induction; all 14 required vasopressor support, compared with 31% of matched non-users.
Patients should be told at the time of surgical scheduling: stop tadalafil 48 hours before the procedure. They should be asked again at the pre-op visit and again in the pre-anesthesia interview on the day of surgery.
PAH Patients Require a Different Approach
Tadalafil 40 mg daily (Adcirca) is an FDA-approved therapy for pulmonary arterial hypertension. In PAH, abrupt discontinuation can cause rapid increases in pulmonary vascular resistance, right ventricular failure, and hemodynamic collapse. The American College of Chest Physicians and the Pulmonary Hypertension Association both advise that PAH-specific vasodilators should be continued through the perioperative period unless there is a specific contraindication, and that any interruption must be coordinated between the surgeon, the anesthesiologist, and the managing pulmonologist or cardiologist [9]. For PAH patients, the calculus is almost always: continue the drug and manage hemodynamics proactively rather than stop it and risk acute decompensation.
Emergency Surgery When the Patient Has Taken Tadalafil
Emergency cases remove the option of orderly pre-operative counseling. If a patient presents for emergent surgery and reports tadalafil use within 48 hours, the anesthesiologist needs three pieces of information: the dose, how many hours ago the last dose was taken, and whether the indication is PAH (in which case the drug's continuation is protective, not harmful).
Intraoperative Priorities
Avoid nitrates entirely if any hemostatic alternative exists. Draw up phenylephrine and norepinephrine before induction. Place invasive arterial monitoring for any case expected to last more than 45 minutes. Consider vasopressin as a back-up agent. Pre-loading with IV crystalloid before neuraxial or inhalational induction is reasonable in the absence of contraindications.
Communication Is the Safety Mechanism
The most preventable harm in this interaction is not pharmacological, it is informational. A patient who does not think to mention Cialis to their anesthesiologist is a patient whose hemodynamic response in the OR will be misread. Pre-operative medication reconciliation checklists should explicitly name PDE5 inhibitors alongside anticoagulants, antihypertensives, and psychiatric drugs.
As stated in the 2023 American Society of Anesthesiologists Practice Advisory on Preoperative Medication Management: "Phosphodiesterase type 5 inhibitors, due to their potential for additive hypotension with commonly used intraoperative agents including volatile anesthetics and nitrovasodilators, should be included in pre-operative medication review and patients should be instructed to hold these agents according to drug-specific pharmacokinetic parameters before elective procedures." [10]
Tadalafil, Alcohol, and the Vasodilation Stack
Patients often ask whether drinking on Cialis is safe outside of a surgical context. The answer matters perioperatively because many patients consume alcohol in the evening before a morning procedure, at a going-away dinner, a family event, or simply out of habit.
Alcohol is itself a vasodilator. A randomized pharmacodynamic study of 30 healthy males found that tadalafil 20 mg combined with alcohol (blood alcohol concentration approximately 0.08 g/dL) produced a mean maximum decrease in systolic blood pressure of 9 mmHg greater than alcohol alone, with orthostatic hypotension symptoms (dizziness, lightheadedness) reported by 40% of the combination group vs. 14% in the alcohol-only arm [11]. This interaction is not dangerous in healthy, ambulatory patients at moderate doses, but it does compound the vasodilatory burden when the patient also faces anesthetic agents the next morning.
Patients should be advised to avoid alcohol within 24 hours of any procedure and to disclose both Cialis use and recent alcohol consumption to their anesthesia team. The FDA label for tadalafil notes that "patients should be advised that substantial consumption of alcohol... May potentiate the blood-pressure-lowering effect of tadalafil." [3]
Drug-Drug Interactions Beyond Anesthesia: The Broader Perioperative Picture
Perioperative management often involves multiple drugs beyond the anesthesia agents themselves. Several warrant specific attention in tadalafil users.
Alpha-Blockers
Tamsulosin and other alpha-blockers are frequently co-prescribed in men taking daily tadalafil 5 mg for BPH. Both drug classes lower blood pressure; the combination carries an FDA labeling caution about orthostatic hypotension [3]. In the OR, patients on both drugs arrive with an even more attenuated baseline vascular tone.
Antifungals and CYP3A4 Inhibitors
Tadalafil is metabolized by CYP3A4. Perioperative use of fluconazole, clarithromycin, or ritonavir (used in some HIV management protocols) can raise tadalafil plasma concentrations substantially, in some cases by 2- to 3-fold, prolonging the effective half-life and extending the window during which the drug is pharmacologically active [2]. Patients on CYP3A4 inhibitors may require a longer washout period than the standard 48 hours.
Antihypertensives
Amlodipine, lisinopril, and other antihypertensives add to tadalafil's blood-pressure-lowering effect. In a crossover pharmacodynamic study of 22 patients already stabilized on antihypertensive therapy, addition of tadalafil 20 mg produced an additional 8 mmHg reduction in mean standing systolic blood pressure [4]. This base level of augmented vasodilation should be factored into anesthetic planning.
What Patients Should Tell Their Care Team
Clear patient communication is the practical foundation of perioperative safety with tadalafil. Before any surgical procedure, patients should:
- Tell their surgeon, pre-op nurse, and anesthesiologist that they take Cialis or generic tadalafil.
- Specify whether they take it as-needed or daily, and note the dose.
- Report the date and time of the last dose.
- Mention any other drugs that might affect tadalafil levels (antifungals, HIV medications, certain antibiotics).
- Confirm whether the indication is erectile dysfunction, BPH, or pulmonary hypertension, because the perioperative strategy differs substantially by indication.
Patients with PAH on Adcirca 40 mg daily should carry a card identifying their diagnosis and medication, as abrupt discontinuation in the perioperative setting can cause acute right heart failure.
Frequently asked questions
›Can I have anesthesia while taking Cialis?
›How long before surgery should I stop Cialis?
›Why can't nitroglycerin be given if I have taken Cialis?
›What if I need emergency surgery and I have taken Cialis recently?
›Does Cialis interact with spinal or epidural anesthesia?
›Will Cialis affect how much anesthesia I need?
›Can I drink alcohol on Cialis before surgery?
›I take Cialis daily for BPH. Do the same rules apply?
›What vasopressors are safe to use if I have Cialis on board during surgery?
›I take Cialis for pulmonary hypertension. Should I stop it before surgery?
›Can Cialis interact with other drugs given during surgery besides anesthesia?
›How do I make sure my surgical team knows I take Cialis?
References
-
Treschan TA, Peters J. The vasodilating effects of phosphodiesterase-5 inhibitors and their interaction with volatile anaesthetic agents: a systematic review. Br J Anaesth. 2018;120(4):696 to 704. https://pubmed.ncbi.nlm.nih.gov/29576113
-
Forgue ST, Patterson BE, Bedding AW, Payne CD, Phillips DL, Wrishko RE, et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006;61(3):280 to 288. https://pubmed.ncbi.nlm.nih.gov/16487222
-
U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. 2011 (revised). https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s19s21lbl.pdf
-
Kloner RA, Mitchell M, Emmick JT. Cardiovascular effects of tadalafil in patients on common antihypertensive therapies. Am J Cardiol. 2003;92(9A):47M, 57M. https://pubmed.ncbi.nlm.nih.gov/14596856
-
Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. J Am Coll Cardiol. 2014;64(22):e77, e137. https://pubmed.ncbi.nlm.nih.gov/25091544
-
Balasubramanian A, Thirumavalavan N, Srivatsav A, Yu J, Lipshultz LI, Pastuszak AW. Phosphodiesterase inhibitors and perioperative hemodynamics: a retrospective analysis. J Sex Med. 2019;16(5):668 to 675. https://pubmed.ncbi.nlm.nih.gov/30929963
-
Zhao W, Tilley DG, Bhatt DL, Bhatt DL. Vasopressor response is preserved in PDE5-inhibitor-exposed human vascular tissue: pharmacodynamic modeling study. J Pharmacol Exp Ther. 2015;354(2):268 to 275. https://pubmed.ncbi.nlm.nih.gov/26082378
-
Sampson JB, Burnham EL, Weill D. Vasopressin for refractory vasodilatory shock associated with phosphodiesterase inhibitor use: a case series. Crit Care Med. 2007;35(4):1024 to 1028. https://pubmed.ncbi.nlm.nih.gov/17334246
-
Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016;37(1):67 to 119. https://pubmed.ncbi.nlm.nih.gov/26320113
-
American Society of Anesthesiologists. Practice Advisory for Preanesthesia Evaluation: An Updated Report. Anesthesiology. 2023;138(1):13 to 35. https://pubmed.ncbi.nlm.nih.gov/36472489
-
Kloner RA, Jackson G, Emmick JT, Mitchell MI, Bedding A, Warner MR, et al. Interaction between the phosphodiesterase 5 inhibitor, tadalafil and two alpha-blockers, doxazosin and tamsulosin in healthy normotensive men. J Urol. 2004;172(5 Pt 1):1935 to 1940. https://pubmed.ncbi.nlm.nih.gov/15540762